Efficacy and safety of etanercept in moderate to severe plaque psoriasis using two different dosing regimens

被引：0
|
作者：
Mazzotta, A [1 ]
Costanzo, A [1 ]
Giunta, A [1 ]
Chimenti, S [1 ]
机构：
[1] Univ Roma Tor Vergata, Dept Dermatol, Rome, Italy
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2006年 / 54卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB201 / AB201
页数：1
相关论文
共 50 条
  • [31] Five-year open-label extension study of safety and efficacy of etanercept in children and adolescents with moderate to severe plaque psoriasis
    Paller, Amy S.
    Siegfried, Elaine C.
    Pariser, David M.
    Rice, Kara Creamer
    Trivedi, Mona
    Iles, Jan
    Collier, David H.
    Kricorian, Greg
    Langley, Richard G.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB251 - AB251
  • [32] Safety and Efficacy of Etanercept Monotherapy for Moderate-to-severe Plaque Psoriasis:A Prospective 12-week Follow-up Study
    解方
    王睿
    赵梓纲
    孟宪芙
    林碧雯
    杨洁
    王文娟
    丁香玉
    杨怡
    赵华
    李承新
    李恒进
    周勇
    [J]. Current Medical Science, 2017, 37 (06) : 943 - 947
  • [33] Safety of oral tazarotene in moderate to severe plaque psoriasis
    Walker, PS
    Gottlieb, A
    Guenther, L
    Menter, A
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P153 - P153
  • [34] Safety and efficacy of etanercept monotherapy for moderate-to-severe plaque psoriasis: A prospective 12-week follow-up study
    Xie, Fang
    Wang, Rui
    Zhao, Zi-gang
    Meng, Xian-fu
    Lin, Bi-wen
    Yang, Jie
    Wang, Wen-juan
    Ding, Xiang-yu
    Yang, Yi
    Zhao, Hua
    Li, Cheng-xin
    Li, Heng-jin
    Zhou, Yong
    [J]. JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2017, 37 (06) : 943 - 947
  • [35] Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials
    Brimhall, A. K.
    King, L. N.
    Licciardone, J. C.
    Jacobe, H.
    Menter, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (02) : 274 - 285
  • [36] Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis
    Strober, B. E.
    Crowley, J. J.
    Yamauchi, P. S.
    Olds, M.
    Williams, D. A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (03) : 661 - 668
  • [37] Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis
    Egeberg, A.
    Ottosen, M. B.
    Gniadecki, R.
    Broesby-Olsen, S.
    Dam, T.
    Bryld, L. E.
    Rasmussen, M. K.
    Skov, L.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E284 - E285
  • [38] Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis
    Egeberg, A.
    Ottosen, M. B.
    Gniadecki, R.
    Broesby-Olsen, S.
    Dam, T. N.
    Bryld, L. E.
    Rasmussen, M. K.
    Skov, L.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (02) : 509 - 519
  • [39] Safety and efficacy of efalizumab therapy for elderly patients with moderate to severe chronic plaque psoriasis
    Gottlieb, A
    Lizzul, P
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P194 - P194
  • [40] Etanercept in patients with moderate to severe plaque psoriasis: a retrospective case cohort analysis
    Perera, G.
    Fonia, A.
    Smith, C.
    Barker, J. N. W. N.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 : 26 - 27
12345